Ryosuke Sakemi

Kitakyushu, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Prevalence and clinical impact of latent tuberculosis infection in patients with inflammatory bowel disease in Japan: a retrospective multicenter study by the IBD-Quality team.

Prevalence and clinical impact of latent tuberculosis infection in patients with inflammatory bowel disease in Japan: a retrospective multicenter study by the IBD-Quality team.

Journal: Journal of gastroenterology

Published: January 23, 2026

Risk of extraintestinal cancer in patients with inflammatory bowel disease: a multicenter retrospective cohort study in Japan.

Risk of extraintestinal cancer in patients with inflammatory bowel disease: a multicenter retrospective cohort study in Japan.

Journal: Journal of gastroenterology

Published: June 23, 2025

Fecal Calprotectin is a Useful Biomarker for Defining Small Bowel Endoscopic Remission in Crohn's Disease Without Active Colonic Lesions: A Prospective Multicenter Study from the IBD-Quality Team.

Fecal Calprotectin is a Useful Biomarker for Defining Small Bowel Endoscopic Remission in Crohn's Disease Without Active Colonic Lesions: A Prospective Multicenter Study from the IBD-Quality Team.

Journal: Inflammatory bowel diseases

Published: December 17, 2024

Evaluation of Serum Calprotectin Levels in Patients with Inflammatory Bowel Disease.

Evaluation of Serum Calprotectin Levels in Patients with Inflammatory Bowel Disease.

Journal: The Kurume medical journal

Published: October 25, 2021

Impact of the Concomitant Use of Immunomodulator and a Lower Week 8 Partial Mayo Score on the Persistence of Adalimumab in Refractory Ulcerative Colitis.

Impact of the Concomitant Use of Immunomodulator and a Lower Week 8 Partial Mayo Score on the Persistence of Adalimumab in Refractory Ulcerative Colitis.

Journal: Internal medicine (Tokyo, Japan)

Published: June 14, 2021

Predicting a rapid response to adalimumab treatment and favorable short-term outcomes through the high platelet count in patients with ulcerative colitis: A multicenter retrospective cohort study.

Predicting a rapid response to adalimumab treatment and favorable short-term outcomes through the high platelet count in patients with ulcerative colitis: A multicenter retrospective cohort study.

Journal: Medicine

Published: November 21, 2020

Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease.

Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease.

Journal: Mediators of inflammation

Published: September 07, 2020

Altered serum profile of the interleukin-22 system in inflammatory bowel disease.

Altered serum profile of the interleukin-22 system in inflammatory bowel disease.

Journal: Cytokine

Published: March 20, 2020

Liver injury caused by exposure to silica and 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123):a case report

Liver injury caused by exposure to silica and 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123):a case report

Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology

Published: November 12, 2019

A nationwide, multi-center, retrospective study of symptomatic small bowel stricture in patients with Crohn's disease.

A nationwide, multi-center, retrospective study of symptomatic small bowel stricture in patients with Crohn's disease.

Journal: Journal of gastroenterology

Published: May 11, 2019

Risk Factors for Mortality in Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease.

Risk Factors for Mortality in Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease.

Journal: Inflammatory intestinal diseases

Published: August 03, 2018

Seven days triple therapy for eradication of Helicobacter pylori does not alter the disease activity of patients with inflammatory bowel disease.

Seven days triple therapy for eradication of Helicobacter pylori does not alter the disease activity of patients with inflammatory bowel disease.

Journal: Intestinal research

Published: March 29, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026